Phlebotomy, Cytoreductive Treatments Are Effective Yet Underused in Older Patients With PV
AJMC.com Managed Markets Network Guidelines indicate that high-risk patients with polycythemia vera (PV) should be treated with phlebotomy and cytoreductive therapy—such as hydroxyurea or interferon-alfa—to reduce the risk of thrombosis, the major cause of death among patients with PV. |
from phlebotomy - Google News http://bit.ly/2yGEit5
No comments:
Post a Comment